Quanterix is proud to participate in AD/PD™ 2025: International Conference on Alzheimer’s and Parkinson’s Diseases, taking place in Vienna, Austria, from April 1–5, 2025. This premier event gathers leading experts, clinicians, and researchers for insightful discussions, workshops, and panels focused on the latest advancements in neurodegenerative disease research. 

We’re excited to connect with you in Vienna and explore how Quanterix can support your groundbreaking research. See you at AD/PD™ 2025! 

📍 Visit us at Booth #22 

Discover our innovative biomarker solutions and gain insights into how we’re transforming neurodegenerative disease detection and treatment. View our full in-booth presentation schedule now.

🎤 Exclusive Insights 

Join Dr. Amanda Heslegrave for an exclusive presentation on the power of ultra-sensitive biomarker research. She will highlight how Simoa® Technology has enabled research across multiple neurological diseases, showcasing key findings from publications that demonstrate its broad impact. Additionally, she will discuss best practices for biomarker research and how researchers can collaborate with her team at the UK Dementia Research Institute.

Don’t miss our exclusive Product Theater session to gain valuable insights into the future of biomarker discovery and disease detection: 

Date: Wednesday, April 2 
Time: 10:40–11:10 AM
Location: Exhibit Hall

Quanterix featured over 80 times at AD/PD 2025

There are over 80 posters, presentations, and sessions at AD/PD™ 2025 that feature Simoa Technology. We invite you to explore this full list of posters and presentations showcasing Quanterix products and services and then come visit us at Booth #22!